Paper30126348
Review of Biguanide (Metformin) Toxicity.
Wang GS and 1 other. J Intensive Care Med, 2019. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. Review of Biguanide (Metformin) Toxicity. Papers, record 30126348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30126348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biguanides | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hypoglycemic Agents | Major topic |
| Metformin | Major topic |
| Renal Insufficiency | Major topic |
| Acidosis | |
| Humans | |
| Hyperlactatemia | |
| Kidney |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42621960 | The Potential of Clerodendrum Plants as an Adjunct Therapeutic for Metabolic Syndrome. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42621960 | PubMed |
| 42113093 | Role and therapeutic potential of icariin in metabolic diseases. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42113093 | PubMed |
| 41948515 | Metformin Toxicity Unmasked by Obstructive Uropathy: A Case of Metformin Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis. | Discoveries (Craiova) | 2026 | https://conductscience.org/library/papers/41948515 | PubMed |
| 41853381 | Allicin modulates the intestinal microbiota to attenuate blood glucose and systemic inflammation in type 2 diabetic rats. | Front Microbiomes | 2023 | https://conductscience.org/library/papers/41853381 | PubMed |
| 41104232 | IDO Inhibition by 1-Methyltryptophan: Unlocking New Paths to Treat Ovarian Dysfunction and Hormonal Imbalance in PCOS. | Iran J Pharm Res | 2025 | https://conductscience.org/library/papers/41104232 | PubMed |
| 41079154 | Regional citrate anticoagulation ensures safe and effective kidney replacement therapy in metformin-associated lactic acidosis. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/41079154 | PubMed |
| 40957477 | The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility. | J Adv Res | 2026 | https://conductscience.org/library/papers/40957477 | PubMed |
| 40733021 | Metformin-Sensitized Chemotherapy of Docetaxel Nanoemulsions Based on a Sequential Administration. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733021 | PubMed |
| 40687580 | Unlocking the dual healing powers of plant-based metallic nanoparticles: managing diabetes and tackling male infertility challenges. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40687580 | PubMed |
| 40524049 | Exploiting the cardioprotective potential of metformin against cardiotoxic agents. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40524049 | PubMed |
| 40465067 | The Effect of Metformin on Astrocytes in Parkinson's Disease: Challenges and Opportunities. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40465067 | PubMed |
| 40429795 | Melatonin Improves Lipid Homeostasis, Mitochondrial Biogenesis, and Antioxidant Defenses in the Liver of Prediabetic Rats. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429795 | PubMed |
| 40366403 | When our treatment is complicated: an overview of drug-induced acid-base disorders: part 1-acidosis. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/40366403 | PubMed |
| 40183261 | Bioactive Phytochemicals: Unlocking the Promise of Natural Remedies for Diabetes Mellitus. | Curr Pharm Biotechnol | 2026 | https://conductscience.org/library/papers/40183261 | PubMed |
| 40080341 | An update on current type 2 diabetes mellitus (T2DM) druggable targets and drugs targeting them. | Mol Divers | 2025 | https://conductscience.org/library/papers/40080341 | PubMed |
| 40042723 | NLRP3 inflammasomes pathway: a key target for Metformin. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40042723 | PubMed |
| 40002709 | Natural Compounds and Histone Deacetylase Inhibitors: A Combined Approach Against mCRPC Cells. | Biomedicines | 2025 | https://conductscience.org/library/papers/40002709 | PubMed |
| 39677160 | A Rare Case of Metformin-Induced Lactic Acidosis and Concomitant Euglycemic Ketoacidosis. | Cureus | 2024 | https://conductscience.org/library/papers/39677160 | PubMed |
| 39585394 | Geroprotective effects of GdVO4:Eu3 + nanoparticles, metformin and calorie restriction in male rats with accelerated aging induced by overnutrition in early postnatal ontogenesis. | Biogerontology | 2024 | https://conductscience.org/library/papers/39585394 | PubMed |
| 39519546 | Plant-Based Diets and Phytochemicals in the Management of Diabetes Mellitus and Prevention of Its Complications: A Review. | Nutrients | 2024 | https://conductscience.org/library/papers/39519546 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30126348
GET https://conductscience.org/api/papers/v1/30126348/cited_by?page=2